Clinical Utility of Next-Generation Sequencing-Based Panel Testing under the Universal Health-Care System in Japan: A Retrospective Analysis at a Single University Hospital

SIMPLE SUMMARY: Next-generation sequencing (NGS)-based assay is widely used in clinical practice due to its reimbursement by Japan’s universal health-care system for cancer patients who finished standard treatment in June 2019. To clarify the clinical utility of the NGS assay under the universal hea...

Descripción completa

Detalles Bibliográficos
Autores principales: Inagaki, Chiaki, Maeda, Daichi, Hatake, Kazue, Sato, Yuki, Hashimoto, Kae, Sakai, Daisuke, Yachida, Shinichi, Nonomura, Norio, Satoh, Taroh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961835/
https://www.ncbi.nlm.nih.gov/pubmed/33807840
http://dx.doi.org/10.3390/cancers13051121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961835/
https://www.ncbi.nlm.nih.gov/pubmed/33807840
http://dx.doi.org/10.3390/cancers13051121

Ejemplares similares